Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,636,522
-$4,943,479 QoQ
Shares Held
17,272
-82.4% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 161 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Derivatives in INBX

reported options exposure · as of Jun 30, 2026
CallValue
$6,840,950
CallShares
72,200
PutValue
$1,222,275
PutShares
12,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. INBX ranks #94 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,636,522 17,272
2026-06-30 $1,222,275 12,900
2026-06-30 $6,840,950 72,200
2026-03-31 $6,580,001 97,873
2026-03-31 $3,549,744 52,800
2026-03-31 $450,441 6,700
2025-12-31 $23,472,164 297,116
2025-12-31 $16,605,800 210,200
2025-12-31 $9,882,900 125,100
2025-09-30 $693,808 20,600
2025-06-30 $329,251 23,073
2025-03-31 $739,693 52,873
2025-03-31 $496,645 35,500
2024-12-31 $177,100 11,500
2024-12-31 $295,680 19,200
2024-12-31 $1,115,760 72,452
2024-09-30 $1,556,118 99,369
2024-09-30 $560,628 35,800
2024-09-30 $220,806 14,100
2024-06-30 $1,806,675 127,500
2024-06-30 $252,226 17,800
2024-06-30 $192,712 13,600